Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease BG Trist, DJ Hare, KL Double Aging cell 18 (6), e13031, 2019 | 510 | 2019 |
Brain iron pathways and their relevance to Parkinson's disease D Berg, M Gerlach, MBH Youdim, KL Double, L Zecca, P Riederer, ... Journal of neurochemistry 79 (2), 225-236, 2001 | 491 | 2001 |
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease H Fedorow, F Tribl, G Halliday, M Gerlach, P Riederer, KL Double Progress in neurobiology 75 (2), 109-124, 2005 | 446 | 2005 |
Language-associated cortical regions are proportionally larger in the female brain J Harasty, KL Double, GM Halliday, JJ Kril, DA McRitchie Archives of neurology 54 (2), 171-176, 1997 | 378 | 1997 |
The relevance of iron in the pathogenesis of Parkinson's disease ME Götz, KAY Double, M Gerlach, MBH Youdim, P RIEDERERE Annals of the New York Academy of Sciences 1012 (1), 193-208, 2004 | 367 | 2004 |
Regional specificity of brain atrophy in Huntington's disease GM Halliday, DA McRitchie, V Macdonald, KL Double, RJ Trent, ... Experimental neurology 154 (2), 663-672, 1998 | 334 | 1998 |
Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson’s disease H Hall, S Reyes, N Landeck, C Bye, G Leanza, K Double, L Thompson, ... Brain 137 (9), 2493-2508, 2014 | 301 | 2014 |
Iron and dopamine: a toxic couple DJ Hare, KL Double Brain 139 (4), 1026-1035, 2016 | 271 | 2016 |
Topography of brain atrophy during normal aging and Alzheimer's disease KL Double, GM Halliday, JJ Krill, JA Harasty, K Cullen, WS Brooks, ... Neurobiology of aging 17 (4), 513-521, 1996 | 265 | 1996 |
α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease GM Halliday, A Ophof, M Broe, PH Jensen, E Kettle, H Fedorow, ... Brain 128 (11), 2654-2664, 2005 | 232 | 2005 |
Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum M Gerlach, K Double, T Arzberger, F Leblhuber, T Tatschner, P Riederer Journal of neural transmission 110, 1119-1127, 2003 | 232 | 2003 |
Copper pathology in vulnerable brain regions in Parkinson's disease KM Davies, S Bohic, A Carmona, R Ortega, V Cottam, DJ Hare, ... Neurobiology of aging 35 (4), 858-866, 2014 | 226 | 2014 |
Iron-binding characteristics of neuromelanin of the human substantia nigra KL Double, M Gerlach, V Schünemann, AX Trautwein, L Zecca, ... Biochemical pharmacology 66 (3), 489-494, 2003 | 221 | 2003 |
In vitro studies of ferritin iron release and neurotoxicity KL Double, M Maywald, M Schmittel, P Riederer, M Gerlach Journal of neurochemistry 70 (6), 2492-2499, 1998 | 213 | 1998 |
The comparative biology of neuromelanin and lipofuscin in the human brain KL Double, VN Dedov, H Fedorow, E Kettle, GM Halliday, B Garner, ... Cellular and Molecular Life Sciences 65, 1669-1682, 2008 | 211 | 2008 |
Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test KL Double, DB Rowe, M Hayes, DKY Chan, J Blackie, A Corbett, R Joffe, ... Archives of neurology 60 (4), 545-549, 2003 | 205 | 2003 |
Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? KL Double, S Reyes, EL Werry, GM Halliday Progress in neurobiology 92 (3), 316-329, 2010 | 149 | 2010 |
Potential sources of increased iron in the substantia nigra of parkinsonian patients M Gerlach, KL Double, MBH Youdim, P Riederer Parkinson’s Disease and Related Disorders, 133-142, 2006 | 149 | 2006 |
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice A Kurz, KL Double, I Lastres-Becker, A Tozzi, M Tantucci, V Bockhart, ... PloS one 5 (7), e11464, 2010 | 148 | 2010 |
Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins KL Double, L Zecca, P Costi, M Mauer, C Griesinger, S Ito, ... Journal of neurochemistry 75 (6), 2583-2589, 2000 | 147 | 2000 |